Olesch, C.; Sirait-Fischer, E.; Berkefeld, M.; Fink, A. F.; Susen, R. M.; Ritter, B.; Michels, B. E.; Steinhilber, D.; Greten, F. R.; Savai, R.et al.; Takeda, K.; Bruene, B.; Weigert, A.: S1PR4 ablation reduces tumor growth and improves chemotherapy via CD8(+) T cell expansion. JOURNAL OF CLINICAL INVESTIGATION 130 (10), pp. 5461 - 5476 (2020)
Baig, M. S.; Roy, A.; Rajpoot, S.; Liu, D.; Savai, R.; Banerjee, S.; Kawada, M.; Faisal, S. M.; Saluja, R.; Saqib, U.et al.; Ohishi, T.; Wary, K. K.: Tumor-derived exosomes in the regulation of macrophage polarization. INFLAMMATION RESEARCH 69 (5), pp. 435 - 451 (2020)
Sarode, P.; Schaefer, M. B.; Grimminger, F.; Seeger, W.; Savai, R.: Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk. FRONTIERS IN ONCOLOGY 10, 324 (2020)
Zheng, X.; Weigert, A.; Reu, S.; Guenther, S.; Mansouri, S.; Bassaly, B.; Gattenlohner, S.; Grimminger, F.; Pullamsetti, S. S.; Seeger, W.et al.; Winter, H.; Savai, R.: Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small Cell Lung Carcinoma. CANCER RESEARCH 80 (20), pp. 4414 - 4425 (2020)
Saqib, U.; Savai, R.; Liu, D.; Banerjee, S.; Baig, M. S.: Drug repositioning as an effective therapy for protease-activated receptor 2 inhibition. JOURNAL OF CELLULAR BIOCHEMISTRY 120 (2), pp. 1522 - 1526 (2019)
Researchers at the Max Planck Institute develop a new pharmacological approach that specifically targets receptor interactions – with implications for immune defense and blood pressure regulation
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).